Welcome to our dedicated page for Amrize news (Ticker: AMRZ), a resource for investors and traders seeking the latest updates and insights on Amrize stock.
Amrize Ltd reports news as a North American building-solutions company serving construction markets from foundation to rooftop. Its updates center on cement, aggregates, ready-mix concrete, asphalt, roofing systems and wall-system products, with segment activity organized around Building Materials and Building Envelope.
Recurring company developments include financial results, pricing and volume trends, margin initiatives, manufacturing and distribution updates, product launches such as high-performance concrete ranges, and capital-allocation actions including dividends and share repurchases. Governance items also appear through annual general meeting results, board and executive changes, and shareholder voting matters.
Amrize (NYSE: AMRZ) announced immediate Board changes: Robert S. Rivkin is appointed Chair of the Audit Committee, Holli Ladhani joins the Audit Committee as a qualified audit committee financial expert, and Theresa Drew resigned from the Board.
The company said Ms. Drew's resignation is not related to any disagreement over operations, policies, or practices. Amrize reported $11.7 billion in 2024 revenue, operates over 1,000 sites, and employs 19,000 teammates.
Amrize (NYSE: AMRZ) will report fourth-quarter 2025 results after U.S. market close on February 17, 2026, followed by a live webcast at 7:30 am CT on February 18, 2026. Registration and materials are available on the company investor website and a replay and transcript will be posted.
Amrize reported $11.7 billion in revenue for 2024, operates over 1,000 sites across the U.S. and Canada, and employs 19,000 teammates. The company is listed on the New York Stock Exchange and the SIX Swiss Exchange.
Amrize (NYSE: AMRZ) agreed to acquire PB Materials, a leading aggregates and ready-mix concrete business in West Texas, expected to close in the first half of 2026 subject to customary closing conditions.
The deal expands Amrize’s footprint by 26 operational sites, adds over 50 years of aggregates reserves in West Texas, brings in more than $180 million of annual revenue, and adds 340 teammates. Management expects the acquisition to create significant synergies and be EPS and cash accretive in 2026.
Amrize (NYSE:AMRZ) commissioned a production expansion at its flagship Ste. Genevieve, Missouri cement plant, adding 660,000 short tons of annual capacity and raising the plant's total to 5.5 million short tons per year.
The project is part of Amrize’s $700 million of investments across operations in 2025, aims to improve operational efficiency, bolster the company’s “Made in America” cement offering, and support local jobs and communities through increased domestic manufacturing and distribution capacity.
Amrize (NYSE: AMRZ) launched a “Made in America” label for its U.S. cement range, certifying that raw materials, processing and manufacturing meet U.S. performance standards and support American jobs and communities. The label will roll out at flagship plants including Ste. Genevieve, MO; Midlothian, TX; Devil’s Slide, UT; Holly Hill, SC; and Portland, CO. The company said it is investing to expand production between Ste. Genevieve and Midlothian as part of $700 million of 2025 investments across operations. Amrize operates 13 U.S. cement plants, about 600 U.S. sites and ~11,000 teammates, positioning itself as a leading domestic cement producer with nationwide distribution.
Amrize (AMRZ) reported third quarter 2025 results with revenues of $3,675M (up 6.6% year-over-year) and free cash flow of $674M (up $221M). Adjusted EBITDA was $1,067M (down 3.3%) and net income was $543M ($0.98 diluted EPS).
Building Materials revenue rose 8.7%; aggregates pricing improved ~10.1%. Building Envelope adjusted EBITDA grew 9.0% with a 190bps margin expansion. A temporary cement equipment outage added ~$50M of costs and reduced margins.
Operating cash flow was $854M. Gross debt was $5,811M, net debt $4,985M and net leverage was 1.7x. Company raised 2025 revenue guidance to $11.7B–$12.0B and confirmed adjusted EBITDA and net leverage guidance.
Amrize (NYSE: AMRZ) will release Q3 2025 financial results after U.S. market close on Tuesday, October 28, 2025. A live webcast to discuss the results will be held at 9:00 AM ET on Wednesday, October 29, 2025. Registration is available at the company webcast link and materials will be posted in the Events section of the investor website. A replay and transcript will be accessible on the investor site after the webcast.
Amrize (NYSE:AMRZ) has announced a strategic partnership with the Chicago Architecture Biennial, North America's largest architecture and design forum. As a "Blueprint" partner, Amrize will collaborate with leading architecture firms, construction partners, and industry experts to advance building design and construction through materials science innovation.
The company, with operational headquarters in Chicago, has contributed to numerous landmark projects including the Lincoln Memorial, One World Trade Center, and the Spheres in Seattle. In Chicago, Amrize's materials have been instrumental in projects like Maggie Daley Park and the 606 trail, demonstrating their commitment to urban development and public spaces.
Amrize (NYSE:AMRZ) has launched the MV Tamarack, a next-generation cement carrier with a capacity exceeding 10,000 cubic meters, strengthening its distribution network. The 12,500 DWT vessel, designed for a 15-year service life, features diesel-electric propulsion and advanced technology to maximize operational efficiency while reducing emissions.
The vessel will support Ontario's $200 billion infrastructure investment plan over the next decade. The Tamarack, owned by Eureka Shipping (a joint venture between CSL Group and SMT Shipping), replaces two older ships and represents the first new cement carrier on the Great Lakes in 20 years.
Amrize (NYSE: AMRZ) has issued a strong recommendation against TRC Capital Investment Corporation's unsolicited mini-tender offer to purchase up to 2 million ordinary shares at $49.63 per share. The offer price represents a 4.48% discount to Amrize's closing price of $51.96 on August 26, 2025.
The company advises shareholders to reject this offer as it represents less than 1% of outstanding shares and is priced below market value. The mini-tender offer, which expires on September 25, 2025, includes conditions that could further disadvantage shareholders, including a provision regarding share price movements.